Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Renal Manifestations”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05507892
What this trial is testing

Renal Mechanism of SGLT2 Inhibition

Who this might be right for
Type 2 DiabetesDiabetic Kidney Disease
University of Colorado, Denver 45
Not applicableStudy completedNCT04006028
What this trial is testing

Kidney Biopsy Indications in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes, Chronic Kidney Disease
Rennes University Hospital 500
Not applicableStudy completedNCT00253786
What this trial is testing

Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy

Who this might be right for
Type 2 Diabetes MellitusDiabetic Nephropathy
Okayama University 312
Testing effectiveness (Phase 2)Study completedNCT00287183
What this trial is testing

6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria

Who this might be right for
Diabetic Nephropathy
Pfizer 110
Not applicableStudy completedNCT07672639
What this trial is testing

Development and Validation of a Machine Learning Model for Differentiating Diabetic Kidney Disease and Non-Diabetic Kidney Disease in Type 2 Diabetes

Who this might be right for
Diabetic Kidney DiseaseType 2 DiabetesChronic Kidney Disease
Beijing Tongren Hospital 2,201
Post-approval studies (Phase 4)Study completedNCT04027530
What this trial is testing

Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseDiabetic Nephropathy+4 more
Amsterdam UMC, location VUmc 40
Early research (Phase 1)Study completedNCT00754143
What this trial is testing

Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy

Who this might be right for
Diabetes MellitusDiabetic Nephropathy
Kyntra Bio 38
Testing effectiveness (Phase 2)Study completedNCT01440257
What this trial is testing

Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria

Who this might be right for
Diabetic NephropathyType 2 Diabetes Mellitus
Amgen 20
Large-scale testing (Phase 3)Study completedNCT00141453
What this trial is testing

ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

Who this might be right for
Diabetic NephropathyType 2 Diabetes MellitusProteinuria
Daiichi Sankyo Co., Ltd. 577
Post-approval studies (Phase 4)WithdrawnNCT03504566
What this trial is testing

Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)

Who this might be right for
Diabetic Nephropathy Type 2
Steno Diabetes Center Copenhagen
Not applicableEnded earlyNCT01101269
What this trial is testing

Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease

Who this might be right for
Type 2 Diabetes
University of Virginia 6
Post-approval studies (Phase 4)Study completedNCT01989754
What this trial is testing

The Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2Albuminuria
Janssen Research & Development, LLC 5,813
Post-approval studies (Phase 4)Ended earlyNCT03029351
What this trial is testing

GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesKidney Diseases
University at Buffalo 15
Large-scale testing (Phase 3)Study completedNCT00130208
What this trial is testing

Effect of Sulodexide in Early Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Keryx Biopharmaceuticals 1,056
Large-scale testing (Phase 3)Not Yet RecruitingNCT06068439
What this trial is testing

Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy Type 2
Second Affiliated Hospital, Zhejiang University, School of Medicine 355
Not applicableLooking for participantsNCT07169422
What this trial is testing

Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care

Who this might be right for
Diabetic Kidney DiseaseType 2 DiabetesChronic Kidney Disease
Nova Scotia Health Authority 120
Not applicableNot Yet RecruitingNCT07707518
What this trial is testing

Evaluating the Effectiveness of a Smart Screening and Tiered Management Tool for Diabetic Kidney Disease in Primary Care: A Cluster Randomized Trial

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney Disease
First Affiliated Hospital of Chongqing Medical University 3,000
Not applicableStudy completedNCT00419484
What this trial is testing

Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesHypertensionDyslipidemia+1 more
Dokkyo Medical University 1,000
Testing effectiveness (Phase 2)Study completedNCT00044148
What this trial is testing

The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes

Who this might be right for
Diabetic Nephropathy
Chromaderm, Inc.
Testing effectiveness (Phase 2)Study completedNCT05514548
What this trial is testing

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Inversago Pharma Inc. 265
Next Page